1
TITLE: Possible survival benefits from zoledronic acid treatment in patients with bone metastases from solid tumours and poor prognostic features-An exploratory analysis of placebo-controlled trials  Full Text
AUTHORS: Robert E Coleman; Allan Lipton; Luis Costa; Richard J Cook; Ker Ai Lee; Fred Saad; Janet E Brown; Evangelos Terpos; Pierre P Major; Norio Kohno; Matthew Smith; Jean Jacques Body;
PUBLISHED: 2013, SOURCE: JOURNAL OF BONE ONCOLOGY, VOLUME: 2, ISSUE: 2
INDEXED IN: Scopus WOS CrossRef
2
TITLE: Denosumab and zoledronic acid treatment in patients with genitourinary cancers and bone metastases
AUTHORS: Luis Costa; Karim Fizazi; Fred Saad; Janet Elizabeth Brown; Roger Von Moos; Stephane Oudard; Cora N Sternberg; Vinod Ganju; Kurt Miller; Huei Wang; Tapan Maniar; Ada Braun;
PUBLISHED: 2013, SOURCE: 49th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) in JOURNAL OF CLINICAL ONCOLOGY, VOLUME: 31, ISSUE: 15
INDEXED IN: WOS
3
TITLE: Consensus on the utility of bone markers in the malignant bone disease setting  Full Text
AUTHORS: Robert Coleman; Luis Costa ; Fred Saad; Richard Cook; Peyman Hadji; Evangelos Terpos; Patrick Garnero; Janet Brown; Jean Jacques Body; Matthew Smith; Ker Ai Lee; Pierre Major; Meletios Dimopoulos; Allan Lipton;
PUBLISHED: 2011, SOURCE: CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, VOLUME: 80, ISSUE: 3
INDEXED IN: Scopus WOS CrossRef
4
TITLE: Optimizing Clinical Benefits of Bisphosphonates in Cancer Patients with Bone Metastases
AUTHORS: Matti Aapro; Fred Saad; Luis Costa ;
PUBLISHED: 2010, SOURCE: ONCOLOGIST, VOLUME: 15, ISSUE: 11
INDEXED IN: Scopus WOS CrossRef